KIT and neoplasm: CD117 overexpression in ovarian CSCs elevates tumor-initiating capacity and chemoresistance against cisplatin/paclitaxel via the induction of the Wnt/beta-catenin-ATP–Binding Cassette Subfamily G Member 2 (ABCG2) axis [46].